Senexon-S 50 mg/1
Docusate Sodium 50mg and Sennosides 8.6mg · TABLET, FILM COATED · NCS HealthCare of KY, LLC dba Vangard Labs
Senexon-S is a tablet, film coated containing docusate sodium 50mg and sennosides 8.6mg at 50 mg/1, taken oral. Manufactured by NCS HealthCare of KY, LLC dba Vangard Labs.
Key Facts
- Brand Name
- Senexon-S
- Generic Name
- Docusate Sodium 50mg and Sennosides 8.6mg
- NDC Code (Product)
0615-8331- Manufacturer
- NCS HealthCare of KY, LLC dba Vangard Labs
- Strength
- 50 mg/1
- Dosage Form
- TABLET, FILM COATED
- Route
- ORAL
- Marketing Status
- Application #
- 505G(a)(3)
- Marketing Start
- 10/02/2019
Recall History
No Recall HistoryFrequently Asked Questions
What is Senexon-S used for?
Senexon-S contains Docusate Sodium 50mg and Sennosides 8.6mg. It is a tablet, film coated taken oral. Consult your doctor for specific uses.
Is Senexon-S a controlled substance?
Senexon-S is not classified as a controlled substance by the DEA.
What is the generic name for Senexon-S?
The generic name for Senexon-S is Docusate Sodium 50mg and Sennosides 8.6mg. There are 1 other brand versions of Docusate Sodium 50mg and Sennosides 8.6mg.
What is the NDC code for Senexon-S 50 mg/1?
The NDC (National Drug Code) for Senexon-S 50 mg/1 is 0615-8331, listed by NCS HealthCare of KY, LLC dba Vangard Labs.